Shuqing Lü

809 total citations
22 papers, 601 citations indexed

About

Shuqing Lü is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Shuqing Lü has authored 22 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Hematology and 4 papers in Oncology. Recurrent topics in Shuqing Lü's work include Acute Myeloid Leukemia Research (6 papers), Ubiquitin and proteasome pathways (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Shuqing Lü is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Ubiquitin and proteasome pathways (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Shuqing Lü collaborates with scholars based in China and United Kingdom. Shuqing Lü's co-authors include Jianmin Wang, Jianmin Yang, Shenglan Gong, Hong Zhou, Zhilong Chen, Lieping Guo, Jianmin Wang, Li Chen, Pingping Chen and Xianmin Song and has published in prestigious journals such as Blood, Journal of Pharmacology and Experimental Therapeutics and Energy storage materials.

In The Last Decade

Shuqing Lü

21 papers receiving 589 citations

Peers

Shuqing Lü
Natalia Zisman Canada
Janice Brown United States
Xiangqin Weng China
Ying Fang China
Magdalena Głowala‐Kosińska Poland
Bindya Jacob Singapore
Mala K. Talekar United States
Patrizia Virdis Italy
Ying Lu China
Natalia Zisman Canada
Shuqing Lü
Citations per year, relative to Shuqing Lü Shuqing Lü (= 1×) peers Natalia Zisman

Countries citing papers authored by Shuqing Lü

Since Specialization
Citations

This map shows the geographic impact of Shuqing Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuqing Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuqing Lü more than expected).

Fields of papers citing papers by Shuqing Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuqing Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuqing Lü. The network helps show where Shuqing Lü may publish in the future.

Co-authorship network of co-authors of Shuqing Lü

This figure shows the co-authorship network connecting the top 25 collaborators of Shuqing Lü. A scholar is included among the top collaborators of Shuqing Lü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuqing Lü. Shuqing Lü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lü, Shuqing, Zhouran Zhang, Yu Tang, Shun Li, & Shuxin Bai. (2024). Enhancing Phase Stability in Low-Activation TiVTa-Based Alloys Through CALPHAD-Guided Design. JOM. 77(3). 1524–1535. 1 indexed citations
2.
Wei, Zhenzhen, et al.. (2023). Reversibly thermo-responsive materials applied in lithium batteries. Energy storage materials. 61. 102901–102901. 24 indexed citations
3.
Pang, Wei Wei, Shuqing Lü, Rong Zheng, et al.. (2022). Investigation into Antiepileptic Effect of Ganoderic Acid A and Its Mechanism in Seizure Rats Induced by Pentylenetetrazole. BioMed Research International. 2022(1). 5940372–5940372. 6 indexed citations
4.
Ai, Xin, Shuqing Lü, Haoran Zhang, et al.. (2021). Fabrication of flexible conductive silk fibroin/polythiophene membrane and its properties. e-Polymers. 22(1). 48–57. 6 indexed citations
5.
Lü, Shuqing, et al.. (2015). High expression of neuroguidin increases the sensitivity of acute myeloid leukemia cells to chemotherapeutic drugs. Journal of Hematology & Oncology. 8(1). 11–11. 1 indexed citations
6.
Lü, Shuqing & Jianmin Wang. (2014). Homoharringtonine and omacetaxine for myeloid hematological malignancies. Journal of Hematology & Oncology. 7(1). 2–2. 121 indexed citations
7.
8.
Song, Xianmin, Xiaoxia Hu, Shuqing Lü, et al.. (2014). Incorporation of arsenic trioxide in induction therapy improves survival of patients with newly diagnosed acute promyelocytic leukaemia. European Journal Of Haematology. 93(1). 54–62. 10 indexed citations
9.
Wang, Libing, Lei Gao, Sheng Xu, et al.. (2013). FISH+CD34+CD38- cells detected in newly diagnosed acute myeloid leukemia patients can predict the clinical outcome. Journal of Hematology & Oncology. 6(1). 85–85. 16 indexed citations
10.
Lü, Shuqing & Jianmin Wang. (2013). The resistance mechanisms of proteasome inhibitor bortezomib. Biomarker Research. 1(1). 13–13. 119 indexed citations
11.
Huang, Chongmei, Xiaoxia Hu, Libing Wang, et al.. (2012). Bortezomib suppresses the growth of leukemia cells with Notch1 overexpression in vivo and in vitro. Cancer Chemotherapy and Pharmacology. 70(6). 801–809. 15 indexed citations
12.
Wang, Jianmin, Shuqing Lü, Jianmin Yang, et al.. (2009). A homoharringtonine-based induction regimen for the treatment of elderly patients with acute myeloid leukemia: a single center experience from China. Journal of Hematology & Oncology. 2(1). 32–32. 26 indexed citations
13.
Lü, Shuqing, Jianmin Yang, Zhilong Chen, et al.. (2009). Different mutants of PSMB5 confer varying bortezomib resistance in T lymphoblastic lymphoma/leukemia cells derived from the Jurkat cell line. Experimental Hematology. 37(7). 831–837. 67 indexed citations
14.
Lü, Shuqing, Zhilong Chen, Jianmin Yang, et al.. (2008). Overexpression of the PSMB5 gene contributes to bortezomib resistance in T-lymphoblastic lymphoma/leukemia cells derived from Jurkat line. Experimental Hematology. 36(10). 1278–1284. 71 indexed citations
15.
Lü, Shuqing, Jianmin Wang, Xiong Ni, et al.. (2008). Bortezomib in combination with epirubicin, dexamethasone and thalidomide is a highly effective regimen in the treatment of multiple myeloma: a single-center experience. International Journal of Hematology. 89(1). 34–38. 9 indexed citations
16.
Lü, Shuqing, Jianmin Yang, Xianmin Song, et al.. (2008). Point Mutation of the Proteasome β5 Subunit Gene Is an Important Mechanism of Bortezomib Resistance in Bortezomib-Selected Variants of Jurkat T Cell Lymphoblastic Lymphoma/Leukemia Line. Journal of Pharmacology and Experimental Therapeutics. 326(2). 423–431. 86 indexed citations
17.
He, Yi, Jian-Min Yang, Jianmin Wang, et al.. (2008). [Synergistic effects of arsenic trioxide and proteasome inhibitor bortezomib on apoptosis induction in Raji cell line].. PubMed. 16(4). 794–8. 5 indexed citations
18.
Lü, Shuqing, Jianmin Wang, Jianmin Yang, et al.. (2007). Amplification and Mutation of PSMB5 Gene in Bortezomib Resistant Lymphoblastic Leukemia Cells Derived from Jurkat Line.. Blood. 110(11). 2373–2373. 2 indexed citations
19.
Chen, Li, Xiaoping Xu, Jianmin Wang, et al.. (2005). [Spectrum of gene expression of a multi-drug resistant leukemia cell line with high tumorigenicity in nude mice].. PubMed. 27(4). 196–200. 2 indexed citations
20.
Lü, Shuqing, Xiaoping Xu, Fang Xia, & Jianmin Wang. (2004). [Differential gene expression analysis of human leukemic cell line with different tumorigenic potentials in nude mice].. PubMed. 26(4). 196–200. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natalia Zisman Breakdown of academic impact, for papers by Janice Brown Breakdown of academic impact, for papers by Xiangqin Weng Breakdown of academic impact, for papers by Ying Fang Breakdown of academic impact, for papers by Magdalena Głowala‐Kosińska Breakdown of academic impact, for papers by Bindya Jacob Breakdown of academic impact, for papers by Mala K. Talekar Breakdown of academic impact, for papers by Patrizia Virdis Breakdown of academic impact, for papers by Ying Lu
Rankless by CCL
2026